Standard Biotools Inc (LAB) returns
Standard Biotools returns over 3 years
$1,000 invested in Standard Biotools three years ago was worth $316.06 at the close on October 30, 2026, with dividends reinvested: an average return of -31.9% a year. The same $1,000 in the S&P 500 (SPY) became $1,885.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -17.6% | — | $823.66 | -0.9% |
| 3 months | -32.0% | — | $679.82 | +2.1% |
| Year to date | -52.3% | — | $476.56 | +11.7% |
| 1 year | -47.0% | — | $530.44 | +12.4% |
| 3 years | -68.4% | -31.9% | $316.06 | +88.5% |
Standard Biotools return by calendar year
| Year | LAB | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -52.3% | +11.7% | -64.0% |
| 2025 | -26.9% | +17.7% | -44.6% |
| 2024 | -20.8% | +24.9% | -45.7% |
| 2023 | +88.9% | +26.2% | +62.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: LAB financials · LAB valuation
No forecast, no recommendation. This page describes Standard Biotools Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.